Currently, molecular alterations in tumors are being scrutinized at a genome-wide scale, covering different dimensions, such as gene expression, epigenetic changes, chromosomal aberrations, and more recently, next generation sequencing. A large number of molecular markers are associated with the development of HCC. that could be useful in the clinic; however, racial differences have been reported, and these need to be examined more thoroughly.